3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Smoking Cessation
7
Tobacco Use Disorder
4
Smoking
2
Lung Neoplasms
2
Uterine Cervical Neoplasms
1
Tobacco Use Cessation
1
Tobacco Use
1
Tobacco Smoking
1
Substance-Related Disorders
1
Neoplasms, Second Primary
1
Neoplasms
1
Cigarette Smoking-Related Carcinoma
1
Behavior, Addictive
1
Interventions
durvalumab
13
Bevacizumab
11
Nivolumab
10
tremelimumab
7
pembrolizumab
6
lenvatinib
6
fludarabine
6
Cyclophosphamide
6
atezolizumab
4
Radiosurgery
4
Cisplatin
4
toripalimab
3
relatlimab
3
Magnetic Resonance Imaging
3
Ipilimumab
3
Gemcitabine
3
X-Rays
2
Standard of Care
2
Sorafenib
2
Riluzole
2
Radiotherapy
2
Photons
2
Patient Navigation
2
Lidocaine
2
Hepatectomy
2
Dexamethasone
2
Biopsy
2
trastuzumab deruxtecan
1
tocilizumab
1
tislelizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Liver Neoplasms
×
Tobacco Use Cessation Devices
×
1 year
×
Clear all
No trials found.